Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ly6/uPAR-Related Protein C4

Published byGiustino Ferdinando Spina Modified over 5 years ago

Similar presentations

Presentation on theme: "Ly6/uPAR-Related Protein C4"— Presentation transcript:

1 Ly6/uPAR-Related Protein C4
Ly6/uPAR-Related Protein C4.4A as a Marker of Solid Growth Pattern and Poor Prognosis in Lung Adenocarcinoma  Benedikte Jacobsen, PhD, Thomas Muley, PhD, Michael Meister, PhD, Hendrik Dienemann, MD, PhD, Ib Jarle Christensen, MSc, Eric Santoni-Rugiu, MD, PhD, Ole Didrik Lærum, MD, PhD, Michael Ploug, PhD  Journal of Thoracic Oncology  Volume 8, Issue 2, Pages (February 2013) DOI: /JTO.0b013e318279d503 Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Scoring of C4.4A. A–D illustrate the staining levels in non–small cell lung cancer on which the scoring of C4.4A was based, with intensities gradually increasing from very weak (A), weak (B), moderate (C), to strong (D) (Scale bars: 50 μm). The correlation between C4.4A scores at the tumor center and periphery is presented as scatter plots for AC and SCC in E and F, respectively. G and H depict box plots of center and periphery scores of C4.4A, delimiting the values for upper and lower quartiles, as divided by pathological stage I–IV (AC to the left and SCC to the right). The median is shown as a line within each box, and the dots represent outliers. AC, adenocarcinoma; SCC, squamous cell carcinoma. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e318279d503) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 C4.4A provides prognostic information in adenocarcinoma but not squamous cell carcinoma patients. Correlation of C4.4A scores with survival of adenocarcinoma and squamous cell carcinoma patients is illustrated by Kaplan–Meier estimates (tumor center score) in A and B, respectively, grouped by their respective tertiles (in red, blue, and green). The number of events (death of all causes), patients at risk at 0, 24, 48, and 72 months, and range of C4.4A scores are indicated below the axis for each tertile. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e318279d503) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 C4.4A is primarily expressed in the solid component of pulmonary adenocarcinomas. Specimens of pulmonary adenocarcinoma were stained with our polyclonal anti-C4.4A antibody and developed with NovaRED chromogen. As shown in the examples of solid, acinar, and papillary growth patterns in A, B, and C, respectively, most C4.4A reactivity is found in solid components. Scale bars: 100 μm. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e318279d503) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Ly6/uPAR-Related Protein C4"

Similar presentations

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.
Prognostic Stratification of Stage IIIA pN2 Non-small Cell Lung Cancer by Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data: An.

Prognostic Stratification of Stage IIIA pN2 Non-small Cell Lung Cancer by Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data: An.
Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA–IIA Squamous Cell Lung Cancer Irrespective.

Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA–IIA Squamous Cell Lung Cancer Irrespective.
Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma  Thomas Schneider,

Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma  Thomas Schneider,
High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer  Jinhong Zhu, Jianqun Ma, Xudong Wang, Tianjiao Ma, Shu Zhang, Wei Wang,
Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3  Thomas Schneider,

Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3  Thomas Schneider,
A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.

A Novel Classification of MUC1 Expression Is Correlated with Tumor Differentiation and Postoperative Prognosis in Non–Small Cell Lung Cancer  Shinjiro.
P63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue  Marco Lo Iacono, PhD, Valentina Monica,

P63 and p73 Isoform Expression in Non-small Cell Lung Cancer and Corresponding Morphological Normal Lung Tissue  Marco Lo Iacono, PhD, Valentina Monica,
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,

Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
Tumor marker expression is predictive of survival in patients with esophageal cancer  Thomas A Aloia, MD, David H Harpole, MD, Carolyn E Reed, MD, Carmen.

Tumor marker expression is predictive of survival in patients with esophageal cancer  Thomas A Aloia, MD, David H Harpole, MD, Carolyn E Reed, MD, Carmen.
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Timon P. H. Buys, BSc, Sarit Aviel-Ronen, MD, Thomas K

Timon P. H. Buys, BSc, Sarit Aviel-Ronen, MD, Thomas K
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer  Mark N. Adams, PhD, Joshua T. Burgess, PhD,

Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer  Mark N. Adams, PhD, Joshua T. Burgess, PhD,
Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,
Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization  Willam Sterlacci, MD, Spasenija Savic, MD, Michael Fiegl,

Putative Stem Cell Markers in Non–Small-Cell Lung Cancer: A Clinicopathologic Characterization  Willam Sterlacci, MD, Spasenija Savic, MD, Michael Fiegl,
Prognostic Impact of CD204-Positive Macrophages in Lung Squamous Cell Carcinoma: Possible Contribution of Cd204-Positive Macrophages to the Tumor-Promoting.

Prognostic Impact of CD204-Positive Macrophages in Lung Squamous Cell Carcinoma: Possible Contribution of Cd204-Positive Macrophages to the Tumor-Promoting.
Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism–related genes  Ruben Pio, PharmD, PhD, Jackeline.

Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism–related genes  Ruben Pio, PharmD, PhD, Jackeline.
Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung Adenocarcinoma  Naoki Yanagawa, MD, PhD, Charles.

Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung Adenocarcinoma  Naoki Yanagawa, MD, PhD, Charles.
Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma  Olga.

Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma  Olga.
Prognostic Stratification of Stage IIIA pN2 Non-small Cell Lung Cancer by Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data: An.

Prognostic Stratification of Stage IIIA pN2 Non-small Cell Lung Cancer by Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data: An.

Similar presentations

Ads by Google